about
Lifestyle and breast cancer recurrences: the DIANA-5 trial.Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study.Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients.Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer.Serum testosterone levels and breast cancer recurrence.Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.Metabolic syndrome as a prognostic factor for breast cancer recurrences.Preventing weight gain during adjuvant chemotherapy for breast cancer: a dietary intervention study.Effect of aerobic exercise intervention on markers of insulin resistance in breast cancer women.Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability.Fruit and vegetable consumption and risk of epithelial ovarian cancer: the European Prospective Investigation into Cancer and Nutrition.Metabolic syndrome and breast cancer prognosisSerum levels of IGF-I and BRCA penetrance: a case control study in breast cancer familiesNutritional advice to breast cancer survivorsA randomized controlled trial of diet and physical activity in BRCA mutation carriersA Pilot Low-Inflammatory Dietary Intervention to Reduce Inflammation and Improve Quality of Life in Patients With Familial Adenomatous Polyposis: Protocol Description and Preliminary ResultsA management system for randomized clinical trials: A novel way to supply medicationMonitoring Vitamin B12 in Women Treated with Metformin for Primary Prevention of Breast Cancer and Age-Related Chronic DiseasesRest-activity rhythm in breast cancer survivors: an update based on non-parametric indices
P50
Q34637407-09EFA894-5255-4676-9F3A-F0522A2C0B75Q35984974-1D3BD51B-C95B-40B0-A63E-8F0644BC1C1FQ36721734-FEF2C143-D341-454D-AE77-81A4F70F3934Q38097730-1CA57FB5-39E3-44BD-BB03-4F20E7667D6FQ41586290-453845E6-0DA5-4712-AA35-73933F450A2EQ42506632-A33297E8-8D43-418B-8361-403C5327AA0BQ44103276-FFE8ADDF-A905-4EE8-BCB8-A39DA4BE6C7EQ45083927-6A5793A4-A73B-4542-A238-38D47AF52946Q46483003-F845CF76-A63B-4A83-A346-AB979A129FBFQ46922126-5097D901-3FF3-4686-93AE-3EE943191340Q47293087-6A15CA64-FB37-4CAB-B8F5-3ECAADE1F6A2Q47613525-0F55388C-EB92-4DDC-BFA1-0FB1AF00D616Q51016187-B9F7A962-BCBE-4229-BD31-A26859A05505Q51832635-D2612042-4BF9-4898-804C-A6EB132C5A21Q60627333-0001629B-B61D-4F59-97E1-A9823157A890Q60627342-744BA9D6-7412-48D0-AEFA-47E6198BB0AAQ61067467-0E307F03-8966-45AD-88A6-62C2889681F2Q61771629-27629C42-E4CF-4399-8D5B-CF1C56A09EABQ64067021-44425E4B-5DF8-4F90-8191-EF7602551BB4Q64114804-A01B1660-0A91-4879-AA5E-1772CF5297DBQ91856992-911E0968-64B8-4993-8C16-039434801F13Q93191118-DAF1E685-D40F-4714-8DA2-4E47C7BC24BC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patrizia Pasanisi
@ast
Patrizia Pasanisi
@en
Patrizia Pasanisi
@es
Patrizia Pasanisi
@sl
type
label
Patrizia Pasanisi
@ast
Patrizia Pasanisi
@en
Patrizia Pasanisi
@es
Patrizia Pasanisi
@sl
prefLabel
Patrizia Pasanisi
@ast
Patrizia Pasanisi
@en
Patrizia Pasanisi
@es
Patrizia Pasanisi
@sl
P1053
F-4908-2017
P106
P1153
6603594296
P21
P31
P3829
P496
0000-0001-6278-3491